From Kfar Saba - Levahan • Infection prevention device developed in Israel helps Corona patients in the city where the world epidemic first broke out

• The Israeli device in China

A respiratory complication device, invented, developed and manufactured in Israel, is used to treat respiratory coronary patients in the Intensive Care Department of Tongji Hospital in Wuhan City, the capital of Hubei Province, China, where the global outbreak of the virus began.

The device is designed to reduce the severe infections that develop in a significant proportion of respiratory patients, thereby increasing the chances of recovery and cure from the serious illness.

Helped doctors recover

According to the World Health Organization, about 5% of corona virus infected need artificial respiration, and about 15% need respiratory help.

Innovative development was transferred to Wahan two weeks ago as part of the reinforcement of medical teams and equipment transferred to the Corona-affected area from all over China, with teams from China-Japan Friendship Hospital and major hospitals in Beijing taking with them the devices invented and manufactured in Israel.

To date, it has been used by about 10 Corona patients, mainly doctors who treated Corona patients who contracted themselves with the virus and were connected to the respirators because of their difficult medical condition.

The facility was invented, developed and manufactured by the start-up company, "Hospitality Soul" from Kfar Saba, which develops instruments for preventing respiratory complications, as well as in research in hospitals in Europe and in Israel - at Rambam Hospitals in Haifa, Wolfson Holon and Salvation Affairs in Bnei Brak.

According to these studies, the use of the device has led to a significant and significant decrease in the infection of patients connected to the respiratory system with pneumonia that can lead to severe complications and even death. The device has already been approved for use in the US, Europe, China and Israel.

Runs 1,200 miles

About two weeks ago, he was transported with medical equipment cargo on the express train from Beijing to Wuhan, a distance of 1,200 kilometers.

So far, it has been used to aid about ten Corona patients, especially doctors who treated themselves with the Corona patients who contracted the virus themselves and were connected to the respirators because of their difficult medical condition.

The device is already in regular use by the Mayo Clinic, Florida, one of the world's leading centers for liver and lung transplants. To date, more than 50 seriously ill patients have been treated at the American Center, many of whom are transplanted.

The device was presented the day before at a Florida hospital meeting for preparation for the Corona expansion in the US. In Israel, it is used in the Rambam Cardiac Intensive Care Department and recently also at Sheba in Tel Hashomer.

A respiratory complication device, invented, developed and manufactured in Israel, is used to treat respiratory coronary patients in the Intensive Care Department of Tongji Hospital in Wuhan City, the capital of Hubei Province, China, where the global outbreak of the virus began.

The device is designed to reduce the severe infections that develop in a significant proportion of respiratory patients, thereby increasing the chances of recovery and cure from the serious illness.

According to the World Health Organization, about 5% of corona virus infected need artificial respiration, and about 15% need respiratory help.

The innovative device was transferred to Wuhan two weeks ago as part of the reinforcement of medical teams and equipment transferred to the affected area in Corona from all over China, when teams from China-Friendship Hospital, the largest hospitals in Beijing, took with them the devices invented and manufactured in Israel.

To date, it has been used by about 10 Corona patients, mainly doctors who treated Corona patients who contracted themselves with the virus and were connected to the respirators because of their difficult medical condition.

It was invented, developed and manufactured by the startup company, Soul Hospice of Kfar Saba, which develops devices to prevent soul complications.

The device is already in regular use by the Mayo Clinic, Florida, one of the world's leading centers for liver and lung transplants. To date, more than 50 serious patients have been treated at the center, many of whom are transplanted.